Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2000-05, Vol.49 (5), p.A19
Hauptverfasser: MIURA, YOSHITAKA, KATO, YOSHIRO, YAMAMOTO, NAOKI, ITATSU, TAKEHARU, OISO, YUTAKA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page A19
container_title Diabetes (New York, N.Y.)
container_volume 49
creator MIURA, YOSHITAKA
KATO, YOSHIRO
YAMAMOTO, NAOKI
ITATSU, TAKEHARU
OISO, YUTAKA
description
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A62891310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A62891310</galeid><sourcerecordid>A62891310</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1720-de625fd5aa5bd5708ff7393835d84d35402a3ece1143b6744f587c666d548e7c3</originalsourceid><addsrcrecordid>eNp90E1Lw0AQBuAcFKzV_7B48mBgN5v9yLFUrcViPcRz2OzOpitpErLrR_31XbCHCkXew8DwMMzMWTLBmGQpEYW4SC69f8cY85hJ8lyOfdO6oH76DtByO4z9Jxh071QNwWn0AsNm7AcVNjvkOvSqgoMuePTlwgaVuwFQdsDgr5Jzq1oP14c6Td4eH8r5U7paL5bz2SptiMhwaoBnzBqmFKsNE1haK2hBJWVG5oayHGeKggZCclpzkeeWSaE554blEoSm0-Tmd26jWqhcZ_swKr11XlcznsmCUIIjujuBGuhgVG281brYPubpCR5jYOv0KX_7x0cS4Ds06sP7Si5W_2xyoLpvW2igiq-Zr4_4Hlebgg8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>MIURA, YOSHITAKA ; KATO, YOSHIRO ; YAMAMOTO, NAOKI ; ITATSU, TAKEHARU ; OISO, YUTAKA</creator><creatorcontrib>MIURA, YOSHITAKA ; KATO, YOSHIRO ; YAMAMOTO, NAOKI ; ITATSU, TAKEHARU ; OISO, YUTAKA</creatorcontrib><identifier>ISSN: 0012-1797</identifier><language>eng</language><publisher>American Diabetes Association</publisher><subject>Complications and side effects ; Diabetic nephropathies ; Drug therapy ; Evaluation ; Troglitazone ; Type 2 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A19</ispartof><rights>COPYRIGHT 2000 American Diabetes Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>MIURA, YOSHITAKA</creatorcontrib><creatorcontrib>KATO, YOSHIRO</creatorcontrib><creatorcontrib>YAMAMOTO, NAOKI</creatorcontrib><creatorcontrib>ITATSU, TAKEHARU</creatorcontrib><creatorcontrib>OISO, YUTAKA</creatorcontrib><title>Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><subject>Complications and side effects</subject><subject>Diabetic nephropathies</subject><subject>Drug therapy</subject><subject>Evaluation</subject><subject>Troglitazone</subject><subject>Type 2 diabetes</subject><issn>0012-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp90E1Lw0AQBuAcFKzV_7B48mBgN5v9yLFUrcViPcRz2OzOpitpErLrR_31XbCHCkXew8DwMMzMWTLBmGQpEYW4SC69f8cY85hJ8lyOfdO6oH76DtByO4z9Jxh071QNwWn0AsNm7AcVNjvkOvSqgoMuePTlwgaVuwFQdsDgr5Jzq1oP14c6Td4eH8r5U7paL5bz2SptiMhwaoBnzBqmFKsNE1haK2hBJWVG5oayHGeKggZCclpzkeeWSaE554blEoSm0-Tmd26jWqhcZ_swKr11XlcznsmCUIIjujuBGuhgVG281brYPubpCR5jYOv0KX_7x0cS4Ds06sP7Si5W_2xyoLpvW2igiq-Zr4_4Hlebgg8</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>MIURA, YOSHITAKA</creator><creator>KATO, YOSHIRO</creator><creator>YAMAMOTO, NAOKI</creator><creator>ITATSU, TAKEHARU</creator><creator>OISO, YUTAKA</creator><general>American Diabetes Association</general><scope>8GL</scope></search><sort><creationdate>20000501</creationdate><title>Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes</title><author>MIURA, YOSHITAKA ; KATO, YOSHIRO ; YAMAMOTO, NAOKI ; ITATSU, TAKEHARU ; OISO, YUTAKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1720-de625fd5aa5bd5708ff7393835d84d35402a3ece1143b6744f587c666d548e7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Complications and side effects</topic><topic>Diabetic nephropathies</topic><topic>Drug therapy</topic><topic>Evaluation</topic><topic>Troglitazone</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MIURA, YOSHITAKA</creatorcontrib><creatorcontrib>KATO, YOSHIRO</creatorcontrib><creatorcontrib>YAMAMOTO, NAOKI</creatorcontrib><creatorcontrib>ITATSU, TAKEHARU</creatorcontrib><creatorcontrib>OISO, YUTAKA</creatorcontrib><collection>Gale In Context: High School</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MIURA, YOSHITAKA</au><au>KATO, YOSHIRO</au><au>YAMAMOTO, NAOKI</au><au>ITATSU, TAKEHARU</au><au>OISO, YUTAKA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>49</volume><issue>5</issue><spage>A19</spage><pages>A19-</pages><issn>0012-1797</issn><pub>American Diabetes Association</pub><tpages>A19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A19
issn 0012-1797
language eng
recordid cdi_gale_infotracmisc_A62891310
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Complications and side effects
Diabetic nephropathies
Drug therapy
Evaluation
Troglitazone
Type 2 diabetes
title Troglitazone Improved Diabetic Nephropathy in Patients with Type 2 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Troglitazone%20Improved%20Diabetic%20Nephropathy%20in%20Patients%20with%20Type%202%20Diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=MIURA,%20YOSHITAKA&rft.date=2000-05-01&rft.volume=49&rft.issue=5&rft.spage=A19&rft.pages=A19-&rft.issn=0012-1797&rft_id=info:doi/&rft_dat=%3Cgale%3EA62891310%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A62891310&rfr_iscdi=true